Treatment of chronic hepatitis C in patients with chronic kidney disease with Sofosbuvir-basead regimes

BACKGROUND: To analyze the effectiveness and the safety of Sofosbuvir-based regimens to treat patients with chronic hepatitis C virus (HCV) infection and chronic kidney disease (CKD). METHODS: A retrospective, observational study in patients with chronic HCV infection and CKD treated with Sofosbuvir...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossato, Giovana, Tovo, Cristiane Valle, Almeida, Paulo Roberto Lerias de
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392030/
https://www.ncbi.nlm.nih.gov/pubmed/31760038
http://dx.doi.org/10.1016/j.bjid.2019.10.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9392030/
https://www.ncbi.nlm.nih.gov/pubmed/31760038
http://dx.doi.org/10.1016/j.bjid.2019.10.011

Ejemplares similares